Jiangsu Yahong Meditech Co., Ltd. (SHA:688176)
China
· Delayed Price · Currency is CNY 17.40
-0.26 (-1.47%)
Mar 10, 2026, 11:29 AM CST
Jiangsu Yahong Meditech Market Cap
Jiangsu Yahong Meditech has a market cap or net worth of 9.93 billion as of March 9, 2026. Its market cap has increased by 148.76% in one year.
Market Cap
9.93B
Enterprise Value
8.56B
Revenue
277.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.40
Market Cap Chart
Since January 7, 2022, Jiangsu Yahong Meditech's market cap has decreased from 10.03B to 9.93B, a decrease of -0.98%. That is a compound annual growth rate of -0.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 9.44B | 45.79% |
| Dec 31, 2025 | 6.47B | 69.77% |
| Dec 31, 2024 | 3.81B | -37.94% |
| Dec 29, 2023 | 6.14B | -4.18% |
| Dec 30, 2022 | 6.41B | -36.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| North China Pharmaceutical Company.Ltd | 9.47B |
| Changzhou Qianhong Biopharma CO.,LTD | 9.54B |
| Chongqing Taiji Industry(Group) Co.,Ltd | 9.30B |
| Shandong Lukang Pharmaceutical | 9.27B |
| KPC Pharmaceuticals,Inc. | 9.11B |
| Zhejiang Xianju Pharmaceutical | 9.02B |
| Shenzhen Neptunus Bioengineering | 8.84B |
| Harbin Pharmaceutical Group | 8.79B |